370 item(s) found
The Science Europe Strategy Plan comes at a crucial time for European Research an Innovation (R&I) and includes an updated vision, mission, values, and set of strategic priorities for the association. It supports its Member Organisation in their mission to create world-class scientific knowledge, delivering more benefit for our societies.
This Multi-annual Action Plan proposes a series of framework actions to guide the implementation of the Science Europe Strategy Plan 2021–2026 in line with the association's updated vision, mission, values, and strategic priorities.
Want to join us and help us strengthen innovative European research? Science Europe currently has an open vacancy for the post of Communications Manager.
Science Europe’s new strategy reflects shifting expectations in both academia and society, says Marc Schiltz
How research policies must adapt: association launches new Strategy Plan 2021-2026 and Multi-annual Action Plan 2021-2026.
On 27 January 2021, Science Europe presented the second, extended version of its Practical Guide to the International Alignment of Research Data Management during a webinar with more than 260 participants.
As it was unfortunately not possible to address all questions participants asked during the launch event, this document presents the answers to the questions asked to both Science Europe and the webinar speakers.
Science Europe signs the Open Letter of the European STI Councils and Advisory Bodies on the participation of Switzerland under Horizon Europe
The interoperability and sustainability of research data are an indispensable element of the shift towards an Open Science system. Join us as we present strategic guidance for research performers, funders, and data infrastructures to help ensure long-term preservation and accessibility of research data.
Group wants “organisational commitment” to better practices and enhanced collaboration
This Practical Guide provides guidance to ensure the long-term preservation and accessibility of research data. Three complementary maturity matrices provide funders, performers, and data infrastructures with a way to create a common understanding of the approaches needed.
‘Publishers have no legitimacy to impose transfer or restrictions of ownership rights on any form of manuscript. In the light of the current pandemic, publisher-dictated embargo periods appear hopelessly antiquated’ highlights Marc Schiltz, President of Science Europe, in this Chemisty World article on the recent CESAER-EUA-Science Europe joint statement on empowering researchers in Open Access.
On 19 May the Science Europe General Assembly accepted the application of two new research organisations to the association: research performing organisation the Eötvös Loránd Research Network (ELKH) from Hungary and the dual research funding and performing organisation the Institute of Health Carlos III (ISCIII) from Spain.
Covid-19 could make researchers more trusted by the public, or damage their reputations significantly? Lidia Borrell-Damián, Secretary General of Science Europe, weights in on the debate.
The year 2020 saw a global pandemic attest to the value of science. In the race for COVID-19 treatments and vaccines, Science Europe’s Member Organisations were at the forefront of the global response and our association became more relevant and important than ever.
Publishing models that restrict researchers’ rights and article reuse blasted as “outdated”
In a joint statement, research-performing and research-funding organisations represented by the European University Association, Science Europe and CESAER, call on all publishers to stop requiring researchers to sign over their rights and to end the use of restrictions and embargoes.
Released in partnership with the CESAER and the European University Association (EUA) this joint statement outlines how all publishers must fully respect researchers’ rights by providing clarity and transparency on Open Access.
CESAER, the European University Association (EUA), and Science Europe call on all publishers to fully respect researchers’ rights and to end the use of restrictions and embargoes.
Commission steps up consultation after “fait accompli” complaints but major concerns remain.
The European Commission approach to the ‘ERA Pact for Research and Innovation in Europe’ should be as inclusive as possible. Its development and implementation need to include research communities, national governments, research organisations, and R&I stakeholders.
